GANINO, LUDOVICA
 Distribuzione geografica
Continente #
AS - Asia 161
NA - Nord America 103
EU - Europa 73
SA - Sud America 7
AF - Africa 3
Totale 347
Nazione #
SG - Singapore 103
US - Stati Uniti d'America 99
IT - Italia 47
HK - Hong Kong 17
CN - Cina 16
DE - Germania 12
VN - Vietnam 10
IN - India 6
BR - Brasile 5
FI - Finlandia 5
GB - Regno Unito 3
NL - Olanda 3
CA - Canada 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AR - Argentina 1
BD - Bangladesh 1
CY - Cipro 1
EG - Egitto 1
ET - Etiopia 1
FR - Francia 1
JO - Giordania 1
KH - Cambogia 1
MN - Mongolia 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
TR - Turchia 1
TW - Taiwan 1
UA - Ucraina 1
Totale 347
Città #
Singapore 59
San Jose 26
Hong Kong 17
Ashburn 15
Munich 11
Santa Clara 7
Los Angeles 6
Milan 6
Beijing 5
Bengaluru 5
Hefei 5
Ho Chi Minh City 5
Seattle 5
Turku 5
Dallas 4
Rome 4
Catanzaro 2
Giugliano in Campania 2
Haiphong 2
Hanoi 2
Naples 2
Phoenix 2
Reggio Calabria 2
San Nicola Manfredi 2
San Polo di Torrile 2
Shantou 2
Solbiate Olona 2
Volla 2
Addis Ababa 1
Amman 1
Asunción 1
Atlanta 1
Barra do Garças 1
Brooklyn 1
Cairo 1
Calgary 1
Campinas 1
Charleston 1
Chhibrāmau 1
Chicago 1
Dubai 1
Dundalk 1
Ealing 1
Elk Grove Village 1
Frankfurt am Main 1
Glenolden 1
González Catán 1
Hermosillo 1
Houston 1
Ibiraci 1
Istanbul 1
Juazeiro do Norte 1
Kansas City 1
Kirkland Lake 1
Luanda 1
Mexico City 1
Mānikganj 1
New York 1
Nicosia 1
North Kansas City 1
Phnom Penh 1
Riyadh 1
Salvador 1
Taipei 1
Tulcea 1
Ulan Bator 1
Vallefiorita 1
Totale 248
Nome #
Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional Study 128
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity (CO-FIRST AUTHOR) 51
Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics Simulations 45
Lipid metabolic vulnerabilities of multiple myeloma (CO-FIRST AUTHOR) 38
Lipid metabolic vulnerabilities of multiple myeloma (CO-FIRST AUTHOR) 36
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma (FIRST AUTHOR) 21
OPA1 as a Cancer Target: Molecular Mechanisms, Structural Insights, and Strategies for Drug Development 20
null 11
Targeting Mitochondrial Vulnerabilities in Chronic Myeloid Leukemia: From Pathobiology to Novel Therapeutic Opportunities 7
Zinc Transporter 8 Autoantibodies in Type 1 Diabetes and Related Diseases: Recent Advancements Towards Future Perspectives 5
Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax 2
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma 1
Dysregulated mitochondrial dynamics in cancer: Unlocking new strategies to combat drug resistance 1
Totale 366
Categoria #
all - tutte 1.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.987


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20246 0 0 0 1 1 0 0 0 0 0 0 4
2024/2025139 2 2 15 25 15 31 23 3 2 0 6 15
2025/2026215 21 16 10 16 36 11 19 24 23 20 16 3
2026/20276 6 0 0 0 0 0 0 0 0 0 0 0
Totale 366